What is Florida Lung?
Florida Lung Asthma And Sleep Specialists (FLASS) operates as a premier healthcare provider, delivering comprehensive diagnostic and therapeutic services for complex pulmonary disorders and sleep-related conditions. With a robust network of five clinical locations, the organization integrates advanced medical technology with a holistic approach to patient wellness. Their service portfolio encompasses critical care, lung cancer screening, and asthma management, all supported by a team of board-certified physicians. By incorporating telemedicine into their operational framework, Florida Lung has effectively modernized the patient experience, ensuring accessibility and continuity of care in an increasingly digital medical landscape.
How much funding has Florida Lung raised?
Florida Lung has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Florida Lung
PPP
Public-Private Partnership
What's next for Florida Lung?
With this late-stage financing, Florida Lung is poised to accelerate its strategic growth initiatives, likely focusing on the scaling of its clinical infrastructure and the integration of cutting-edge treatment modalities. The organization is expected to prioritize the expansion of its telemedicine capabilities and the enhancement of its diagnostic facilities to meet the rising demand for specialized respiratory care. As the practice continues to solidify its market position, the focus will remain on maintaining high-quality clinical outcomes while exploring potential partnerships that align with its mission of patient empowerment and education. This capital deployment serves as a critical catalyst for long-term sustainability and service excellence in the pulmonary medicine sector.
See full Florida Lung company page
